Raidionostics

Innovating Diagnostics. Empowering Care.

Advanced Radiology, Nuclear medicine, and other comprehensive Interdisciplinary diagnostics and theragnostic solutions from a clinician-led consortium. Uniting multispecialty subject matter experts under one umbrella to deliver truly integrated diagnostic excellence.

Portfolio of Clinical Solutions

Years Experience

0 +

About rAIdionostics

rAIdionostics is a clinician-led consortium delivering advanced solutions in diagnostic imaging, radiology, nuclear medicine, and theragnostics. With a vision to enhance accessibility, accuracy, and efficiency in healthcare, we merge clinical insight with cutting-edge technology. From AI-powered reporting to modular radiopharmacy systems, our mission is to transform care delivery across public and private sectors. Our unique strength lies in bringing together radiologists, physicists, scientists, software engineers, and clinical specialists — offering unparalleled multispecialty expertise in diagnostics.

At rAIdionostics, we bring together clinical expertise, cutting-edge imaging technology, and a deep commitment to quality to transform how diagnostic and theragnostic services are delivered. Our mission is to provide intelligent, sustainable solutions across nuclear medicine, radiology, and molecular imaging—designed not just for today, but for the future of patient care.

Najeeb Ahmed
Medical Director

Case Studies & Pilot Projects

Case Study 2

Transforming Hybrid Imaging Services with End-to-End Clinical Support

A partner institution reached out to us following persistent concerns over the quality and consistency of their nuclear medicine and PET/CT reporting. A particular challenge was the accurate interpretation of hybrid cross-sectional imaging, especially SPECT/CT, where nuanced clinical judgement is essential.

rAIdionostics responded by providing expert interpretation of both SPECT and PET/CT studies, utilising advanced hybrid imaging reporting tools to deliver structured, clinically meaningful reports.

But our support extended well beyond reporting. We provided full ARSAC-level supervisory input, ensuring not only regulatory compliance but also the establishment of a clinically robust and safe service. Unlike transactional providers, our focus is on forming long-term, collaborative partnerships—embedding into local workflows, supporting multidisciplinary teams, and raising the overall standard of reporting.

This approach is particularly critical in nuclear medicine, where clinician oversight before and during image acquisition plays a far more integral role compared to conventional radiology workflows.

The outcome was clear: greater clinical confidence, improved report clarity, and a stronger, more resilient imaging service. At rAIdionostics, our commitment to expertise, innovation, and sustainable collaboration continues to reshape expectations for nuclear medicine reporting.

Case study 3

In many regions, patients face significant challenges in accessing timely ultrasound (US) imaging. Long hospital waiting lists, the need to travel to larger centres, and limited transport options create serious barriers — especially for the elderly, people with disabilities, and those living in rural or underserved areas.

Recognising this gap, we are in the process of developing an agile, community-based ultrasound service aimed at bringing diagnostics closer to patients. The goal is simple: make ultrasound more accessible, flexible, and responsive to local needs.

The idea began with a question from GPs and patients alike: why must people travel long distances or wait weeks for a simple scan? For many, attending hospital-based imaging appointments involves lengthy journeys, unreliable public transport, or needing to take time off work or arrange for carers — all for a 15-minute procedure.

We are currently developing a pilot project in conjunction with primary care colleagues in a region where distances are a major barrier. Early feedback from clinicians and patients has been overwhelmingly positive, with potentially reduced wait times and improved convenience noted as likely key benefits.

As the service evolves and get deployed, we will work to ensure it meets all clinical, digital, and safety standards while remaining adaptable to different communities. By addressing regional inequalities in access to care, this project has the potential to change how — and where — ultrasound is delivered.

Why Choose Us ?

Clinician-led and evidence-driven

At rAIdionostics, we believe that the future of healthcare lies at the intersection of clinical expertise and scientific rigor. Our solutions are designed by clinicians, for clinicians — ensuring real-world relevance, accuracy, and patient-centered impact.

Trusted by academic and NHS collaborators

Through collaborative research, pilot studies, and real-world clinical deployments, we work hand-in-hand with frontline healthcare providers and academic researchers to ensure our solutions are not only innovative but also rigorously validated and practically effective.

AI-integrated solutions

Our AI algorithms are seamlessly integrated into the clinical decision-making process — supporting clinicians with faster, data-driven insights without disrupting existing systems. From radiology to pathology, our tools are built to assist

Preclinical PET Research to Clinical Delivery

From Preclinical PET Research to Clinical Delivery of Integrated Imaging & Theragnostic Solutions we offer comprehensive expertise across molecular research, preclinical PET imaging, nuclear medicine, and clinical radiology

Transforming Hybrid Imaging Services with End-to-End Clinical Support

rAIdionostics responded by providing expert interpretation of both SPECT and PET/CT studies, utilising advanced hybrid imaging reporting tools to deliver structured, clinically meaningful reports.

This approach is particularly critical in nuclear medicine, where clinician oversight before and during image acquisition plays a far more integral role compared to conventional radiology workflows.